JP Morgan Chase’s Guardant Health GH Stock Holding History

JP Morgan Chase’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,600	Closed	-$74.3K	–	7517
2024 Q1	$74.3K	Buy	+3,600	New	+$77.2K	﹤0.01%	5787
2023 Q1	–	Sell	-1,024,000	Closed	-$27.9M	–	6896
2022 Q4	$27.9M	Buy	1,024,000 +839,000	+454%	+$38.4M	﹤0.01%	1428
2022 Q3	$9.96M	Buy	185,000 +184,600	+46,150%	+$9.48M	﹤0.01%	2153
2022 Q2	$16K	Buy	+400	New	+$19.8K	﹤0.01%	5934
2019 Q4	–	Sell	-150,000	Closed	-$9.57M	–	5710
2019 Q3	$9.57M	Buy	+150,000	New	+$13.2M	﹤0.01%	2163
2019 Q2	–	Sell	-300	Closed	-$23K	–	5841
2019 Q1	$23K	Buy	+300	New	+$16.6K	﹤0.01%	5371

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's GH Position: Q1 2026 in Review

JP Morgan Chase increased its Guardant Health (GH) stake by 12% in Q1 2026, buying an estimated $3.34M and bringing the position to 304,317 shares worth $26.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1856.

JP Morgan Chase first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $126M in Q3 2019. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

JP Morgan Chase held 304,317 shares of Guardant Health worth $26.2M as of Q1 2026.
JP Morgan Chase bought 33,278 Guardant Health shares in Q1 2026, an estimated $3.34M.
Guardant Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1856 holding.
JP Morgan Chase first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
JP Morgan Chase's Guardant Health position peaked at $126M in Q3 2019.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.